Market Tracker

09/23 6:02pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

During the Trading Day
11.31 +0.10 / +0.89%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
11.29 -0.02 / -0.18%
 
Volume: 70.1K

Today’s Trading

Previous close11.21
Today’s open10.50
Day’s range10.45 - 11.36
Volume8,475,786
Average volume (3 months)4,545,801
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 09/23/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+44.91%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales7.99
Price/Book92.29

Competitors

 Today’s
change
Today’s
% change
THRXTheravance Inc-0.50-2.77%
IPXLImpax Laboratories I...-0.27-1.10%
RAREUltragenyx Pharmaceu...+1.28+2.36%
IRWDIronwood Pharmaceuti...-0.08-0.65%
Data as of 3:59pm ET, 09/23/2014

Financials

Next reporting dateNovember 25, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts